Safety of Nintedanib in Real World in China

A Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary Arterial Hypertension

NCT00853112 ·Status: TERMINATED ·Phase: PHASE2

Open-label, Multi-center Protocol to Provide QTI571 to PAH Patients Who Participated in the Extension Study (A2301E1) in Japan

NCT02042014 ·Status: COMPLETED ·Phase: PHASE3

Efficacy, Safety, and Tolerability Study of Pirfenidone in Combination With Sildenafil in Participants With Advanced Idiopathic Pulmonary Fibrosis (IPF) and Intermediate or High Probability of Group 3 Pulmonary Hypertension

NCT02951429 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate Long Term Safety and Efficacy of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis

NCT04594707 ·Status: TERMINATED ·Phase: PHASE3

Safety and Efficacy of Imatinib Mesylate in Patients With Pulmonary Arterial Hypertension

NCT00477269 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Post-Marketing Surveillance of Ventavis® in Chinese Patients With Primary Pulmonary Hypertension (PPH)

NCT00882947 ·Status: COMPLETED

Bosentan in Pulmonary Hypertension in Interstitial Lung Disease Treatment Study

NCT00637065 ·Status: UNKNOWN ·Phase: PHASE4

Acute Haemodynamic Study of TPN171H in Patients with Pulmonary Arterial Hypertension

NCT04483115 ·Status: COMPLETED ·Phase: PHASE2

Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Fibrosis and Treatment With Bosentan

NCT00625469 ·Status: WITHDRAWN ·Phase: PHASE4

A Phase 2 Study of IkT-001Pro in Pulmonary Arterial Hypertension (PAH)

NCT06643143 ·Status: WITHDRAWN ·Phase: PHASE2

Study of the Initial Combination of Bosentan With Iloprost in the Treatment of Pulmonary Hypertension Patients

NCT01712997 ·Status: UNKNOWN ·Phase: PHASE3

Long-Term Open-Label, Safety Study Of Sitaxentan Sodium In Japanese Pulmonary Arterial Hypertension Patients

NCT01210443 ·Status: TERMINATED ·Phase: PHASE3

Efficacy, Safety, Tolerability and Pharmacokinetics (PK) of Nilotinib (AMN107) in Pulmonary Arterial Hypertension (PAH)

NCT01179737 ·Status: TERMINATED ·Phase: PHASE2

Study of BSF 208075 Evaluating Exercise Capacity in Patients With Pulmonary Arterial Hypertension

NCT00046319 ·Status: COMPLETED ·Phase: PHASE2

Safety and Effectiveness of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease

NCT00345774 ·Status: COMPLETED ·Phase: PHASE2

Study on the Treatment of Nonthrombotic Obstructive Pulmonary Hypertension

NCT06980584 ·Status: RECRUITING ·Phase: NA

Safety Surveillance of Targeted Drugs for Pulmonary Hypertension Using a Computerized Follow-up System: a Nationwide Cohort Study

NCT05372263 ·Status: RECRUITING

A Study on the Efficacy and Safety of Empagliflozin in the Treatment of Pulmonary Arterial Hypertension

NCT06554301 ·Status: RECRUITING ·Phase: PHASE1

Extension to QTI571A2301 to Evaluate the Long-term Safety, Tolerability and Efficacy of Imatinib in Severe Pulmonary Arterial Hypertension (PAH)

NCT01117987 ·Status: TERMINATED ·Phase: PHASE3

Bioenergetic Effect of Pioglitazone in CLD-PH

NCT06336798 ·Status: RECRUITING ·Phase: PHASE2

Side Effects of Pulmonary Hypertension Medications

NCT01571713 ·Status: COMPLETED

Inhaled Iloprost in Adults With Abnormal Pulmonary Pressure and Associated With Idiopathic Pulmonary Fibrosis

NCT00109681 ·Status: COMPLETED ·Phase: PHASE2

Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis

NCT02603068 ·Status: WITHDRAWN ·Phase: PHASE2

A Study of HS135 for the Treatment of Pulmonary Arterial Hypertension in Adults

NCT06493461 ·Status: TERMINATED ·Phase: PHASE1

A 12 Week Safety And Efficacy Study Of Sitaxentan Sodium In Japanese Pulmonary Arterial Hypertension Patients

NCT01204853 ·Status: TERMINATED ·Phase: PHASE3